PECS Block for Postoperative Pain in Children

This trial tests a new method to manage pain after surgery for children receiving a Cardiac Implantable Electronic Device (CIED). It examines whether a pectoral nerve block (a technique to numb the chest area) can reduce the need for opioids post-surgery, compared to direct wound numbing. The study uses bupivacaine (a local anesthetic) combined with epinephrine to evaluate this technique. Children aged 3-18 undergoing CIED surgery on their chest are suitable candidates for this trial. As a Phase 4 trial, this research involves an FDA-approved treatment, aiming to understand its benefits for a broader patient population.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.

Previous studies have shown that bupivacaine with epinephrine is generally well-tolerated for pectoral nerve blocks. These studies indicate that this treatment effectively reduces the need for opioids (strong painkillers) after surgery, demonstrating good pain management. However, reports of serious side effects, such as heart problems, have occurred, particularly if the dosage is not carefully controlled.

Researchers are excited about the PECS block technique for managing postoperative pain in children because it offers a targeted approach to pain relief by delivering bupivacaine 0.25% with epinephrine directly to the fascial planes identified in PECS I and II. This method could potentially reduce the need for systemic pain medications, which often come with side effects. Unlike traditional methods that may involve higher doses or systemic administration, the PECS block uses a precise, localized delivery that minimizes exposure while effectively managing pain at the surgical site. This could lead to better pain management outcomes and faster recovery times for children undergoing surgery.

This trial will compare the effectiveness of two postoperative pain management strategies in children: the PECS block and wound infiltration. Research has shown that pectoral nerve blocks with bupivacaine and epinephrine, as used in the PECS block arm of this trial, can reduce postoperative pain. Studies have found that patients receiving this treatment reported less pain and required fewer opioid painkillers. Specifically, one study noted that these nerve blocks reduced pain and opioid use in children after heart device surgeries. This suggests that the treatment can enhance recovery by better managing pain. Overall, using bupivacaine in this manner has been linked to improved pain control after surgery.¹⁶⁷⁸⁹